Addition Therapeutics
$106.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Addition Therapeutics is currently valued at N/A as of December 17, 2025. The company has raised a total of $187.5M in funding.
Investment Perspective
Addition Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Addition Therapeutics Worth in 2025?
As of 2025, Addition Therapeutics is valued at N/A, based on the company's Early Stage VC funding round in December 17, 2025. This valuation positions Addition Therapeutics as one of the leading private companies in the sector.
Addition Therapeutics Valuation History
Addition Therapeutics's funding history demonstrates steady growth and investor confidence.
How Addition Therapeutics Valuation is Determined
Private company valuations like Addition Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Addition Therapeutics Valuation FAQs
Is Addition Therapeutics profitable?
Addition Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Addition Therapeutics's valuation compare to competitors?
Addition Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Addition Therapeutics IPO?
Addition Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Addition Therapeutics shares through secondary market platforms.